These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26872563)

  • 1. Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening.
    Hoorens I; Vossaert K; Ongenae K; Brochez L
    Br J Dermatol; 2016 Jun; 174(6):1258-65. PubMed ID: 26872563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying patients at risk for recurrent or advanced BCC.
    Hamid O; Goldenberg G
    J Drugs Dermatol; 2013 Nov; 12(11):1246-52; quiz 1253-4. PubMed ID: 24196332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is new in basal cell carcinoma?].
    Heppt M; von Braunmühl T; Berking C
    Hautarzt; 2016 Nov; 67(11):876-883. PubMed ID: 27654826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods.
    Kauvar AN; Cronin T; Roenigk R; Hruza G; Bennett R;
    Dermatol Surg; 2015 May; 41(5):550-71. PubMed ID: 25868035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost comparisons of managing complex facial basal cell carcinoma: Canadian study.
    Lear W; Mittmann N; Barnes E; Breen D; Murray C
    J Cutan Med Surg; 2008; 12(2):82-7. PubMed ID: 18346405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional versus streamlined management of basal cell carcinoma (BCC): A cost analysis.
    Wu X; Elkin EB; Jason Chen CS; Marghoob A
    J Am Acad Dermatol; 2015 Nov; 73(5):791-8. PubMed ID: 26341142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
    Newlands C; Currie R; Memon A; Whitaker S; Woolford T
    J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.
    Essers BA; Dirksen CD; Nieman FH; Smeets NW; Krekels GA; Prins MH; Neumann HA
    Arch Dermatol; 2006 Feb; 142(2):187-94. PubMed ID: 16490846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma.
    Erdem GU; Sendur MA; Ozdemir NY; Yazıcı O; Zengin N
    Curr Med Res Opin; 2015 Apr; 31(4):743-56. PubMed ID: 25690490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vismodegib as a neoadjuvant treatment to Mohs surgery for aggressive basal cell carcinoma.
    Alcalay J; Tauber G; Fenig E; Hodak E
    J Drugs Dermatol; 2015 Mar; 14(3):219-23. PubMed ID: 25738842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsurgical treatment options for basal cell carcinoma - focus on advanced disease.
    Goldenberg G; Hamid O
    J Drugs Dermatol; 2013 Dec; 12(12):1369-78. PubMed ID: 24301238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023.
    Peris K; Fargnoli MC; Kaufmann R; Arenberger P; Bastholt L; Seguin NB; Bataille V; Brochez L; Del Marmol V; Dummer R; Forsea AM; Gaudy-Marqueste C; Harwood CA; Hauschild A; Höller C; Kandolf L; Kellerners-Smeets NWJ; Lallas A; Leiter U; Malvehy J; Marinović B; Mijuskovic Z; Moreno-Ramirez D; Nagore E; Nathan P; Stratigos AJ; Stockfleth E; Tagliaferri L; Trakatelli M; Vieira R; Zalaudek I; Garbe C;
    Eur J Cancer; 2023 Oct; 192():113254. PubMed ID: 37604067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal cell carcinoma--new aspects of diagnosis and treatment.
    Wennberg AM
    Acta Derm Venereol Suppl (Stockh); 2000; 209():5-25. PubMed ID: 10884941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current landscape for treatment of advanced basal cell carcinoma.
    Foley P
    Australas J Dermatol; 2015 Mar; 56 Suppl 1():1-7. PubMed ID: 25715811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of basal cell carcinoma in USA.
    Wu X; Elkin EE; Marghoob AA
    Future Oncol; 2015 Nov; 11(22):2967-74. PubMed ID: 26466906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
    Peris K; Fargnoli MC; Garbe C; Kaufmann R; Bastholt L; Seguin NB; Bataille V; Marmol VD; Dummer R; Harwood CA; Hauschild A; Höller C; Haedersdal M; Malvehy J; Middleton MR; Morton CA; Nagore E; Stratigos AJ; Szeimies RM; Tagliaferri L; Trakatelli M; Zalaudek I; Eggermont A; Grob JJ;
    Eur J Cancer; 2019 Sep; 118():10-34. PubMed ID: 31288208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
    Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
    Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and Management of Basal Cell Carcinoma.
    Tanese K
    Curr Treat Options Oncol; 2019 Feb; 20(2):13. PubMed ID: 30741348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.
    Chang AL; Solomon JA; Hainsworth JD; Goldberg L; McKenna E; Day BM; Chen DM; Weiss GJ
    J Am Acad Dermatol; 2014 Jan; 70(1):60-9. PubMed ID: 24189279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.